The Latest Breaking News from Hims & Hers’

Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.

These blue chips rallied hard while a few big winners in 2024 faltered. American Airlines is setting up.

Hims stock jumped early Tuesday after the online pharmacy beat expectations, helped by Hims & Hers' weight-loss drug.

Hims stock rallied almost 22% over two days on enthusiasm after the FDA said it will allow compounded versions of Lilly's obesity drug.

Hims & Hers is a digital health company that is firing on all cylinders, while improving its profit margins at a robust pace.

The compounded weight loss drug starts at $199 per month.

Telehealth company Hims & Hers is trading near record highs after issuing strong guidance for the full year ahead. With the stock up nearly 145% in the last six months, how much more upside is left for HIMS?

Online, direct-to-consumer health care has grown well beyond its roots mostly treating hair loss and acne or selling birth control pills

Your need-to-knows.

When Pat Paulson’s son told her he was feeling anxious and depressed at college, Paulson went through her Blue Cross Blue Shield provider directory and started calling mental health therapists. No providers in the Wisconsin city where her son’s university is located had openings. So she bought a monthly subscription…